Vericel® Corporation Email Format
Biotechnology ResearchMassachusetts, United States201-500 Employees
Vericel Corporation operates in the biotechnology research industry, focusing on advanced therapies for sports medicine and severe burn care. The company combines innovations in biology with medical technologies to offer a portfolio of autologous cell therapies and specialty biologics. In the United States, Vericel markets two autologous cell therapy products and one specialty biologic. The company is based in Cambridge, Massachusetts, at 64 Sidney Sreet, and employs 201-500 people; its website is vcel.com. Recent developments include expanding offices to Burlington, Massachusetts to serve as the company’s global headquarters, and a BARDA contract for NexoBrid that covers procurement, the establishment and maintenance of a Vendor Managed Inventory system, the design and validation of a U.S.-based manufacturing facility, and the development of a next generation formulation and additional indication.